SCHEMBL23957178

SCHEMBL23957178

CCCCCCC(CCCCC)CN1CCCC1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.45
ALDH1A1 P00352 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
LTA4H P09960 1/20 0.39
CHRM2 P08172 1/20 0.39
HTR1A P08908 1/20 0.39
ADRA2A P08913 1/20 0.39
ADORA3 P0DMS8 1/20 0.39
CHRM1 P11229 1/20 0.39
SLC6A2 P23975 1/20 0.39
SLC6A4 P31645 1/20 0.39
OPRM1 P35372 1/20 0.39
DRD3 P35462 1/20 0.39
SLC6A3 Q01959 1/20 0.39
KCNH2 Q12809 1/20 0.39
CYP2D6 P10635 1/20 0.39
MEN1 O00255 1/20 0.37
KMT2A Q03164 1/20 0.37
OPRL1 P41146 1/20 0.36
UGCG Q16739 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28887787 1.00 LMNA (0.45) LMNAALDH1A1L3MBTL1LTA4HCHRM2
SCHEMBL24404816 1.00 LMNA (0.45) LMNAALDH1A1L3MBTL1LTA4HCHRM2
SCHEMBL3229094 0.98 LMNA (0.43) LMNAALDH1A1L3MBTL1LTA4HCHRM2
SCHEMBL22236667 0.98 LMNA (0.43) LMNAALDH1A1L3MBTL1LTA4HCHRM2
SCHEMBL22390592 0.98 LMNA (0.43) LMNAALDH1A1L3MBTL1LTA4HCHRM2
SCHEMBL22236670 0.98 LMNA (0.43) LMNAALDH1A1L3MBTL1LTA4HCHRM2
SCHEMBL10290344 0.92 CHRM2 (0.47) LMNAALDH1A1L3MBTL1LTA4HCHRM2
SCHEMBL23899583 0.92 OPRM1 (0.42) LMNAALDH1A1L3MBTL1LTA4HCHRM2
SCHEMBL14086800 0.88 SLC6A4 (0.42) LMNAALDH1A1L3MBTL1LTA4HCHRM2
SCHEMBL12715776 0.87 L3MBTL1 (0.39) LMNAALDH1A1L3MBTL1LTA4HCHRM2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210332007-A1 DIARYLUREAS AS CB1 ALLOSTERIC MODULATORS RESEARCH TRIANGLE INSTITUTE 2021-10-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210332007-A1 DIARYLUREAS AS CB1 ALLOSTERIC MODULATORS CNR1, CNR2, GPR18 LMNA 4699/4885ALDH1A1 2918/4885L3MBTL1 4628/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.